These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 10674688)

  • 1. Short report: treatment of snake envenomations by a new polyvalent antivenom composed of highly purified F(ab)2: results of a clinical trial in northern Cameroon.
    Chippaux JP; Lang J; Amadi-Eddine S; Fagot P; Le Mener V
    Am J Trop Med Hyg; 1999 Dec; 61(6):1017-8. PubMed ID: 10674688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical safety of a polyvalent F(ab')2 equine antivenom in 223 African snake envenomations: a field trial in Cameroon. VAO (Venin Afrique de l'Ouest) Investigators.
    Chippaux JP; Lang J; Eddine SA; Fagot P; Rage V; Peyrieux JC; Le Mener V
    Trans R Soc Trop Med Hyg; 1998; 92(6):657-62. PubMed ID: 10326114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous
    Kurtović T; Karabuva S; Grenc D; Dobaja Borak M; Križaj I; Lukšić B; Halassy B; Brvar M
    Toxins (Basel); 2021 Apr; 13(4):. PubMed ID: 33919927
    [No Abstract]   [Full Text] [Related]  

  • 4. [Snake bite by European vipers. A multicenter study of tolerance to Viperfav, a new intravenous antivenom].
    de Haro L; Lang J; Bedry R; Guelon D; Harry P; Marchal-Mazet F; Jouglard J
    Ann Fr Anesth Reanim; 1998; 17(7):681-7. PubMed ID: 9750806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First clinical experiences with a new ovine Fab Echis ocellatus snake bite antivenom in Nigeria: randomized comparative trial with Institute Pasteur Serum (Ipser) Africa antivenom.
    Meyer WP; Habib AG; Onayade AA; Yakubu A; Smith DC; Nasidi A; Daudu IJ; Warrell DA; Theakston RD
    Am J Trop Med Hyg; 1997 Mar; 56(3):291-300. PubMed ID: 9129531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of F(ab')2 versus Fab antivenom for pit viper envenomation: a prospective, blinded, multicenter, randomized clinical trial.
    Bush SP; Ruha AM; Seifert SA; Morgan DL; Lewis BJ; Arnold TC; Clark RF; Meggs WJ; Toschlog EA; Borron SW; Figge GR; Sollee DR; Shirazi FM; Wolk R; de Chazal I; Quan D; García-Ubbelohde W; Alagón A; Gerkin RD; Boyer LV
    Clin Toxicol (Phila); 2015 Jan; 53(1):37-45. PubMed ID: 25361165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical study of tolerance and effectiveness of a F(ab')(2) polyvalent antienom for African snake bites in Kindia, Guinea].
    Baldé MC; Chippaux JP; Boiro MY; Stock R; Massougbodji A
    Bull Soc Pathol Exot; 2012 Aug; 105(3):157-61. PubMed ID: 22359185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low incidence of early reactions to horse-derived F(ab')(2) antivenom for snakebites in Thailand.
    Thiansookon A; Rojnuckarin P
    Acta Trop; 2008 Feb; 105(2):203-5. PubMed ID: 17996842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective multicenter observational study of Viperidae polyvalent immune F(ab')
    Vanni M; Intorre L; Corazza M; Meucci V; Parti S
    J Vet Emerg Crit Care (San Antonio); 2020 Jan; 30(1):34-40. PubMed ID: 31858721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new F(ab')
    Lasoff DR; Ruha AM; Curry SC; Koh C; Clark RF
    Am J Emerg Med; 2016 Oct; 34(10):2003-2006. PubMed ID: 27567423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of a new polyvalent antivenom against snakebite envenomation (Inoserp® Panafricain) in two different epidemiological settings: Northern Benin and Maritime Guinea].
    Chippaux JP; Baldé MC; Sessinou É; Yéro Boiro M; Massougbodji A
    Med Sante Trop; 2015; 25(1):56-64. PubMed ID: 25847880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subacute coagulopathy in a randomized, comparative trial of Fab and F(ab')2 antivenoms.
    Boyer LV; Chase PB; Degan JA; Figge G; Buelna-Romero A; Luchetti C; Alagón A
    Toxicon; 2013 Nov; 74():101-8. PubMed ID: 23948058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First clinical experiences with specific sheep Fab fragments in snake bite. Report of a multicentre study of Vipera berus envenoming.
    Karlson-Stiber C; Persson H; Heath A; Smith D; al-Abdulla IH; Sjöström L
    J Intern Med; 1997 Jan; 241(1):53-8. PubMed ID: 9042094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent and persistent coagulopathy following pit viper envenomation.
    Boyer LV; Seifert SA; Clark RF; McNally JT; Williams SR; Nordt SP; Walter FG; Dart RC
    Arch Intern Med; 1999 Apr; 159(7):706-10. PubMed ID: 10218750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viper bite with continuous defibrination despite adequate treatment with antivenom.
    Jacob J
    J Assoc Physicians India; 2006 Sep; 54():733-4. PubMed ID: 17212024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute adverse events associated with the administration of Crotalidae polyvalent immune Fab antivenom within the North American Snakebite Registry.
    Kleinschmidt K; Ruha AM; Campleman S; Brent J; Wax P;
    Clin Toxicol (Phila); 2018 Nov; 56(11):1115-1120. PubMed ID: 29688079
    [No Abstract]   [Full Text] [Related]  

  • 17. Severe Pit Viper Envenomation with Extended Clinical Signs and Treatment Complications in a Dog.
    Schaer M; Buckley GJ; Conner BJ; Cuddy LC; Vigani A; Vansickle AE; Coisman JG; DeVuyst DR; Bandt C
    J Am Anim Hosp Assoc; 2015; 51(5):329-37. PubMed ID: 26355585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy, safety, and use of snake antivenoms in the United States.
    Dart RC; McNally J
    Ann Emerg Med; 2001 Feb; 37(2):181-8. PubMed ID: 11174237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tracheal intubation prevented with administration of Fab antivenom after severe crotaline envenomation.
    Bebarta VS; Ferre RM; Peck M
    J Emerg Med; 2010 Jul; 39(1):e81-3. PubMed ID: 18722730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. European viper envenomings: Assessment of Viperfav™ and other symptomatic treatments.
    Boels D; Hamel JF; Bretaudeau Deguigne M; Harry P
    Clin Toxicol (Phila); 2012 Mar; 50(3):189-96. PubMed ID: 22372786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.